OMOP Concept 36934136
0.4 ML mepolizumab 100 MG/ML Injectable Solution [Nucala] by Glaxosmithkline
StandardDrugRxNorm ExtensionOMOP5207644Marketed Product
Maps from
1
Descendants
0
Valid from
22 May 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Source codes that map to this concept
1 source code normalizes to 0.4 ML mepolizumab 100 MG/ML Injectable Solution [Nucala] by Glaxosmithkline via the OMOP "Maps to" relationship.
| Vocabulary | Code | Name | Type |
|---|---|---|---|
| dm+d | 41447811000001107 | Nucala 40mg/0.4ml solution for injection pre-filled syringes | Non-standard |
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(18)Roll up to these when you need a wider cohort.
- 10.4 ML mepolizumab 100 MG/ML Injectable Solution
- 10.4 ML mepolizumab 100 MG/ML Injectable Solution [Nucala]
- 1mepolizumab 100 MG/ML Injectable Solution
- 1mepolizumab 100 MG/ML Injectable Solution [Nucala]
- 2mepolizumab 100 MG/ML
- 2mepolizumab 100 MG/ML [Nucala]
- 2mepolizumab Injectable Solution
- 2mepolizumab Injectable Solution [Nucala]
- 3mepolizumab
- 3mepolizumab; parenteral
- 4Anti-IL-5 antibody
- 4Other systemic drugs for obstructive airway diseases
- 5Immunosuppressive monoclonal antibody
- 5OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
- 6Antibody medication
- 6DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
- 6Immunosuppressant
- 7RESPIRATORY SYSTEM
Get this concept via the API
Resolve 0.4 ML mepolizumab 100 MG/ML Injectable Solution [Nucala] by Glaxosmithkline - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/36934136?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card